Aurobindo Pharma informs about updates

05 Feb 2024 Evaluate
Aurobindo Pharma has informed that Eugia US Manufacturing LLC, USA, a wholly owned step-down subsidiary of the Company, has entered into an asset purchase agreement with Empower Clinic Services New Jersey, LLC to dispose of its business assets as a going concern with related assets and liabilities and employees. Eugia US Manufacturing LLC is not a material subsidiary of the Company and accordingly, the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part B of Schedule III of the aforesaid regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023, is enclosed as 'Annexure I'.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1256.25 15.55 (1.25%)
23-Dec-2024 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.45
Dr. Reddys Lab 1349.60
Cipla 1482.05
Lupin 2181.90
Zydus Lifesciences 977.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.